Stephen Maxted Ansell, MD, PhD

  • 20939 Citations
  • 77 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1983 2019

Article
23 Citations (Scopus)

5-fluorouracil and leucovorin in hepatocellular carcinoma

Van Eeden, H., Falkson, G., Burger, W. & Ansell, S. M., 1992, In : Annals of Oncology. 3, 5, p. 404-405 2 p.

Research output: Contribution to journalArticle

Leucovorin
Liver Neoplasms
Combination Drug Therapy
Fluorouracil
Hepatocellular Carcinoma
58 Citations (Scopus)

A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling

Hildebrand, J. M., Luo, Z., Manske, M. K., Price-Troska, T., Ziesmer, S. C., Lin, W., Hostager, B. S., Slager, S. L., Witzig, T. E., Ansell, S. M., Cerhan, J. R., Bishop, G. A. & Novak, A. J., Nov 22 2010, In : Journal of Experimental Medicine. 207, 12, p. 2569-2579 11 p.

Research output: Contribution to journalArticle

B-Cell Activation Factor Receptor
Non-Hodgkin's Lymphoma
Mutation
TNF Receptor-Associated Factor 6
TNF Receptor-Associated Factor 3
78 Citations (Scopus)

Absolute lymphocyte count predicts overall survival in follicular lymphomas

Siddiqui, M., Ristow, K., Markovic, S. N., Witzig, T. E., Habermann, T. M., Colgan, J. P., Inwards, D. J., White, W. L., Ansell, S. M., Micallef, I., Johnston, P. B., Call, T. G. & Porrata, L. F., Sep 2006, In : British Journal of Haematology. 134, 6, p. 596-601 6 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Lymphocyte Count
Survival
Stem Cell Transplantation
Hematologic Neoplasms
18 Citations (Scopus)

Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas [9]

Porrata, L. F., Ristow, K., Witzig, T. E., Tuinistra, N., Habermann, T. M., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B. & Markovic, S. N., Dec 2007, In : Leukemia. 21, 12, p. 2554-2556 3 p.

Research output: Contribution to journalArticle

Yttrium Radioisotopes
Neoplasm Drug Resistance
Radioimmunotherapy
Salvage Therapy
Follicular Lymphoma
46 Citations (Scopus)

Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas

Behl, D., Ristow, K., Markovic, S. N., Witzig, T. E., Habermann, T. M., Colgan, J. P., Inwards, D. J., White, W. L., Ansell, S. M., Micallef, I., Johnston, P. B. & Porrata, L. F., Jun 2007, In : British Journal of Haematology. 137, 5, p. 409-415 7 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Lymphocyte Count
Therapeutics
Rituximab
Immune System
41 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Monocytes
Survival
Disease-Free Survival
190 Citations (Scopus)

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

Dispenzieri, A., Lacy, M., Katzmann, J. A., Rajkumar, S. V., Abraham, R. S., Hayman, S. R., Kumar, S. K., Clark, R., Kyle, R. A., Litzow, M. R., Inwards, D. J., Ansell, S. M., Micallef, I., Porrata, L. F., Elliott, M. A., Johnston, P. B., Greipp, P. R., Witzig, T. E., Zeldenrust, S. R., Russell, S. J. & 2 others, Gastineau, D. & Gertz, M., Apr 15 2006, In : Blood. 107, 8, p. 3378-3383 6 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Peripheral Blood Stem Cell Transplantation
Stem cells
Immunoglobulins
Blood

Acalabrutinib in mantle cell lymphoma

Kapoor, P. & Ansell, S. M., Jan 1 2017, (Accepted/In press) In : The Lancet.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
acalabrutinib
3 Citations (Scopus)

Accuracy of self-reported tobacco use status among hematopoietic SCT patients

Ehlers, S. L., Bronars, C. A., Patten, C. A., Brockman, T., Hughes, C., Decker, P. A., Cerhan, J. R., Hogan, W., Dispenzieri, A., Ansell, S. M., Ebbert, J. O. & Gastineau, D., 2014, In : Bone Marrow Transplantation. 49, 7, p. 961-965 5 p.

Research output: Contribution to journalArticle

Tobacco Use
Cotinine
Serum
Sensitivity and Specificity
Secondary Prevention
48 Citations (Scopus)

Activation of TAK1 by MYD88 L265P drives malignant B-cell growth in non-Hodgkin lymphoma

Ansell, S. M., Hodge, L. S., Secreto, F. J., Manske, M., Braggio, E. D., Price-Troska, T., Ziesmer, S., Li, Y., Johnson, S. H., Hart, S., Kocher, J-P., Vasmatzis, G., Chanan Khan, A. A., Gertz, M., Fonseca, R., Dogan, A., Cerhan, J. R. & Novak, A. J., 2014, In : Blood Cancer Journal. 4, 2, 20144.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Non-Hodgkin's Lymphoma
B-Lymphocytes
Growth
TNF Receptor-Associated Factor 6
10 Citations (Scopus)
B-Cell Lymphoma
Interleukin-12
Non-Hodgkin's Lymphoma
Monoclonal Antibodies
Cytokines
6 Citations (Scopus)
Anaplastic Large-Cell Lymphoma
T-Cell Lymphoma
Non-Hodgkin's Lymphoma
Molecular Biology
Randomized Controlled Trials
34 Citations (Scopus)

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Huet, S., Tesson, B., Jais, J. P., Feldman, A. L., Magnano, L., Thomas, E., Traverse-Glehen, A., Albaud, B., Carrère, M., Xerri, L., Ansell, S. M., Baseggio, L., Reyes, C., Tarte, K., Boyault, S., Haioun, C., Link, B. K., Feugier, P., Lopez-Guillermo, A., Tilly, H. & 10 others, Brice, P., Hayette, S., Jardin, F., Offner, F., Sujobert, P., Gentien, D., Viari, A., Campo, E., Cerhan, J. R. & Salles, G., Apr 1 2018, In : The Lancet Oncology. 19, 4, p. 549-561 13 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Gene Expression Profiling
Disease-Free Survival
Paraffin
Formaldehyde
29 Citations (Scopus)

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

Vijai, J., Wang, Z., Berndt, S. I., Skibola, C. F., Slager, S. L., De Sanjose, S., Melbye, M., Glimelius, B., Bracci, P. M., Conde, L., Birmann, B. M., Wang, S. S., Brooks-Wilson, A. R., Lan, Q., De Bakker, P. I. W., Vermeulen, R. C. H., Portlock, C., Ansell, S. M., Link, B. K., Riby, J. & 82 others, North, K. E., Gu, J., Hjalgrim, H., Cozen, W., Becker, N., Teras, L. R., Spinelli, J. J., Turner, J., Zhang, Y., Purdue, M. P., Giles, G. G., Kelly, R. S., Zeleniuch-Jacquotte, A., Ennas, M. G., Monnereau, A., Bertrand, K. A., Albanes, D., Lightfoot, T., Yeager, M., Chung, C. C., Burdett, L., Hutchinson, A., Lawrence, C., Montalvan, R., Liang, L., Huang, J., Ma, B., Villano, D. J., Maria, A., Corines, M., Thomas, T., Novak, A. J., Dogan, A., Liebow, M., Thompson, C. A., Witzig, T. E., Habermann, T. M., Weiner, G. J., Smith, M. T., Holly, E. A., Jackson, R. D., Tinker, L. F., Ye, Y., Adami, H. O., Smedby, K. E., De Roos, A. J., Hartge, P., Morton, L. M., Severson, R. K., Benavente, Y., Boffetta, P., Brennan, P., Foretova, L., Maynadie, M., McKay, J., Staines, A., DIver, W. R., Vajdic, C. M., Armstrong, B. K., Kricker, A., Zheng, T., Holford, T. R., Severi, G., Vineis, P., Ferri, G. M., Ricco, R., Miligi, L., Clavel, J., Giovannucci, E., Kraft, P., Virtamo, J., Smith, A., Kane, E., Roman, E., Chiu, B. C. H., Fraumeni, J. F., Wu, X., Cerhan, J. R., Offit, K., Chanock, S. J., Rothman, N. & Nieters, A., Jan 8 2015, In : Nature Communications. 6, 6751.

Research output: Contribution to journalArticle

HLA-B Antigens
genome
Genome-Wide Association Study
loci
Lymphoma
158 Citations (Scopus)

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Parrilla Castellar, E. R., Jaffe, E. S., Said, J. W., Swerdlow, S. H., Ketterling, R. P., Knudson, R. A., Sidhu, J. S., Hsi, E. D., Karikehalli, S., Jiang, L., Vasmatzis, G., Gibson, S. E., Ondrejka, S., Nicolae, A., Grogg, K. L., Allmer, C., Ristow, K. M., Wilson, W. H., Macon, W. R., Law, M. E. & 6 others, Cerhan, J. R., Habermann, T. M., Ansell, S. M., Dogan, A., Maurer, M. J. & Feldman, A. L., Aug 28 2014, In : Blood. 124, 9, p. 1473-1480 8 p., 1284.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
anaplastic lymphoma kinase
Clinical Pathology
Chemotherapy
T-cells
41 Citations (Scopus)

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

Elliott, M. A., Tefferi, A., Hogan, W., Letendre, L., Gastineau, D. A., Ansell, S. M., Dispenzieri, A., Gertz, M., Hayman, S. R., Inwards, D. J., Lacy, M., Micallef, I., Porrata, L. F. & Litzow, M. R., Jun 2006, In : Bone Marrow Transplantation. 37, 11, p. 1003-1008 6 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Stem Cell Transplantation
Tissue Donors
Lymphocytes
Transplants
43 Citations (Scopus)

AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantion in non-Hodgkin lymphoma

Holtan, S. G., Porrata, L. F., Micallef, I., Padley, D. J., Inwards, D. J., Ansell, S. M., Johnston, P. B., Gastineau, D. A. & Markovic, S. N., Jan 2007, In : Clinical Lymphoma and Myeloma. 7, 4, p. 315-318 4 p.

Research output: Contribution to journalArticle

Autografts
Non-Hodgkin's Lymphoma
Disease-Free Survival
Stem Cells
Lymphocytes
43 Citations (Scopus)

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

Cozen, W., Timofeeva, M. N., Li, D., Diepstra, A., Hazelett, D., Delahaye-Sourdeix, M., Edlund, C. K., Franke, L., Rostgaard, K., Van Den Berg, D. J., Cortessis, V. K., Smedby, K. E., Glaser, S. L., Westra, H. J., Robison, L. L., Mack, T. M., Ghesquieres, H., Hwang, A. E., Nieters, A., De Sanjose, S. & 47 others, Lightfoot, T., Becker, N., Maynadie, M., Foretova, L., Roman, E., Benavente, Y., Rand, K. A., Nathwani, B. N., Glimelius, B., Staines, A., Boffetta, P., Link, B. K., Kiemeney, L., Ansell, S. M., Bhatia, S., Strong, L. C., Galan, P., Vatten, L., Habermann, T. M., Duell, E. J., Lake, A., Veenstra, R. N., Visser, L., Liu, Y., Urayama, K. Y., Montgomery, D., Gaborieau, V., Weiss, L. M., Byrnes, G., Lathrop, M., Cocco, P., Best, T., Skol, A. D., Adami, H. O., Melbye, M., Cerhan, J. R., Gallagher, A., Taylor, G. M., Slager, S. L., Brennan, P., Coetzee, G. A., Conti, D. V., Onel, K., Jarrett, R. F., Hjalgrim, H., Van Den Berg, A. & McKay, J. D., Jun 12 2014, In : Nature Communications. 5, 3856.

Research output: Contribution to journalArticle

loci
Hodgkin Disease
Meta-Analysis
Genes
magnetic permeability

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Immunotherapy
Lymphoma
Hodgkin Disease
63 Citations (Scopus)

Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

Sampson, J. N., Wheeler, W. A., Yeager, M., Panagiotou, O., Wang, Z., Berndt, S. I., Lan, Q., Abnet, C. C., Amundadottir, L. T., Figueroa, J. D., Landi, M. T., Mirabello, L., Savage, S. A., Taylor, P. R., De Vivo, I., McGlynn, K. A., Purdue, M. P., Rajaraman, P., Adami, H. O., Ahlbom, A. & 388 others, Albanes, D., Amary, M. F., An, S. J., Andersson, U., Andriole, G., Andrulis, I. L., Angelucci, E., Ansell, S. M., Arici, C., Armstrong, B. K., Arslan, A. A., Austin, M. A., Baris, D., Barkauskas, D. A., Bassig, B. A., Becker, N., Benavente, Y., Benhamou, S., Berg, C., Van Den Berg, D., Bernstein, L., Bertrand, K. A., Birmann, B. M., Black, A., Shanafelt, T. D., Boffetta, P., Boutron-Ruault, M. C., Bracci, P. M., Brinton, L., Brooks-Wilson, A. R., Bueno-De-Mesquita, H. B., Burdett, L., Buring, J., Butler, M. A., Cai, Q., Cancel-Tassin, G., Canzian, F., Carrato, A., Carreon, T., Carta, A., Chan, J. K. C., Chang, E. T., Chang, G. C., Chang, I. S., Chang, J., Chang-Claude, J., Chen, C. J., Chen, C. Y., Chen, C., Chen, C. H., Chen, C., Chen, H., Chen, K., Chen, K. Y., Chen, K. C., Chen, Y., Chen, Y. H., Chen, Y. S., Chen, Y. M., Chien, L. H., Chirlaque, M. D., Choi, J. E., Choi, Y. Y., Chow, W. H., Chung, C. C., Clavel, J., Clavel-Chapelon, F., Cocco, P., Colt, J. S., Comperat, E., Conde, L., Connors, J. M., Conti, D., Cortessis, V. K., Cotterchio, M., Cozen, W., Crouch, S., Crous-Bou, M., Cussenot, O., Davis, F. G., Ding, T., Diver, W. R., Dorronsoro, M., Dossus, L., Duell, E. J., Ennas, M. G., Erickson, R. L., Feychting, M., Flanagan, A. M., Foretova, L., Fraumeni, J. F., Freedman, N. D., Freeman, L. E. B., Fuchs, C., Gago-Dominguez, M., Gallinger, S., Gao, Y. T., Gapstur, S. M., Garcia-Closas, M., García-Closas, R., Gascoyne, R. D., Gastier-Foster, J., Gaudet, M. M., Gaziano, J. M., Giffen, C., Giles, G. G., Giovannucci, E., Glimelius, B., Goggins, M., Gokgoz, N., Goldstein, A. M., Gorlick, R., Gross, M., Grubb, R., Gu, J., Guan, P., Gunter, M., Guo, H., Habermann, T. M., Haiman, C. A., Halai, D., Hallmans, G., Hassan, M., Hattinger, C., He, Q., He, X., Helzlsouer, K., Henderson, B., Henriksson, R., Hjalgrim, H., Hoffman-Bolton, J., Hohensee, C., Holford, T. R., Holly, E. A., Hong, Y. C., Hoover, R. N., Horn-Ross, P. L., Hosain, G. M. M., Hosgood, H. D., Hsiao, C. F., Hu, N., Hu, W., Hu, Z., Huang, M. S., Huerta, J. M., Hung, J. Y., Hutchinson, A., Inskip, P. D., Jackson, R. D., Jacobs, E. J., Jenab, M., Jeon, H. S., Ji, B. T., Jin, G., Jin, L., Johansen, C., Johnson, A., Jung, Y. J., Kaaks, R., Kamineni, A., Kane, E., Kang, C. H., Karagas, M. R., Kelly, R. S., Khaw, K. T., Kim, C., Kim, H. N., Kim, J. H., Kim, J. S., Kim, Y. H., Kim, Y. T., Kim, Y. C., Kitahara, C. M., Klein, A. P., Klein, R. J., Kogevinas, M., Kohno, T., Kolonel, L. N., Kooperberg, C., Kricker, A., Krogh, V., Kunitoh, H., Kurtz, R. C., Kweon, S. S., La Croix, A., Lawrence, C., Lecanda, F., Lee, V. H. F., Li, D., Li, H., Li, J., Li, Y. J., Li, Y., Liao, L. M., Liebow, M., Lightfoot, T., Lim, W. Y., Lin, C. C., Lin, D., Lindstrom, S., Linet, M. S., Link, B. K., Liu, C., Liu, J., Liu, L., Ljungberg, B., Lloreta, J., Di Lollo, S., Lu, D., Lund, E., Malats, N., Mannisto, S., Marchand, L. L., Marina, N., Masala, G., Mastrangelo, G., Matsuo, K., Maynadie, M., McKay, J., McKean-Cowdin, R., Melbye, M., Melin, B. S., Michaud, D. S., Mitsudomi, T., Monnereau, A., Montalvan, R., Moore, L. E., Mortensen, L. M., Nieters, A., North, K. E., Novak, A. J., Oberg, A. L., Offit, K., Oh, I. J., Olson, S. H., Palli, D., Pao, W., Park, I. K., Park, J. Y., Park, K. H., Patiño-Garcia, A., Pavanello, S., Peeters, P. H. M., Perng, R. P., Peters, U., Petersen, G. M., Picci, P., Pike, M. C., Porru, S., Prescott, J., Prokunina-Olsson, L., Qian, B., Qiao, Y. L., Rais, M., Riboli, E., Riby, J., Risch, H. A., Rizzato, C., Rodabough, R., Roman, E., Roupret, M., Ruder, A. M., De Sanjose, S., Scelo, G., Schned, A., Schumacher, F., Schwartz, K., Schwenn, M., Scotlandi, K., Seow, A., Serra, C., Serra, M., Sesso, H. D., Setiawan, V. W., Severi, G., Severson, R. K., Shanafelt, T. D., Shen, H., Shen, W., Shin, M. H., Shiraishi, K., Shu, X. O., Siddiq, A., Sierrasesúmaga, L., Sihoe, A. D. L., Skibola, C. F., Smith, A., Smith, M. T., Southey, M. C., Spinelli, J. J., Staines, A., Stampfer, M., Stern, M. C., Stevens, V. L., Stolzenberg-Solomon, R. S., Su, J., Su, W. C., Sund, M., Sung, J. S., Sung, S. W., Tan, W., Tang, W., Tardón, A., Thomas, D., Thompson, C. A., Tinker, L. F., Tirabosco, R., Tjønneland, A., Travis, R. C., Trichopoulos, D., Tsai, F. Y., Tsai, Y. H., Tucker, M., Turner, J., Vajdic, C. M., Vermeulen, R. C. H., Villano, D. J., Vineis, P., Virtamo, J., Visvanathan, K., Wactawski-Wende, J., Wang, C., Wang, C. L., Wang, J. C., Wang, J., Wei, F., Weiderpass, E., Weiner, G. J., Weinstein, S., Wentzensen, N., White, E., Witzig, T. E., Wolpin, B. M., Wong, M. P., Wu, C., Wu, G., Wu, J., Wu, T., Wu, W., Wu, X., Wu, Y. L., Wunder, J. S., Xiang, Y. B., Xu, J., Xu, P., Yang, P. C., Yang, T. Y., Ye, Y., Yin, Z., Yokota, J., Yoon, H. I., Yu, C. J., Yu, H., Yu, K., Yuan, J. M., Zelenetz, A., Zeleniuch-Jacquotte, A., Zhang, X. C., Zhang, Y., Zhao, X., Zhao, Z., Zheng, H., Zheng, T., Zheng, W., Zhou, B., Zhu, M., Zucca, M., Boca, S. M., Cerhan, J. R., Ferri, G. M., Hartge, P., Hsiung, C. A., Magnani, C., Miligi, L., Morton, L. M., Smedby, K. E., Teras, L. R., Vijai, J., Wang, S. S., Brennan, P., Caporaso, N. E., Hunter, D. J., Kraft, P., Rothman, N., Silverman, D. T., Slager, S. L., Chanock, S. J. & Chatterjee, N., 2016, In : Journal of the National Cancer Institute. 107, 12, djv279.

Research output: Contribution to journalArticle

Genome-Wide Association Study
Smoking
Neoplasms
Lung Neoplasms
Confidence Intervals
245 Citations (Scopus)

An APRIL to remember: Novel TNF ligands as therapeutic targets

Dillon, S. R., Gross, J. A., Ansell, S. M. & Novak, A. J., Mar 2006, In : Nature Reviews Drug Discovery. 5, 3, p. 235-246 12 p.

Research output: Contribution to journalArticle

Ligands
Autoimmunity
B-Lymphocytes
Therapeutics
Neoplasms
3 Citations (Scopus)
Continuing Medical Education
Risk Management
Hematologic Neoplasms
Hodgkin Disease
Drug Therapy

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease

An RNA aptamer-based biomarker platform demonstrates high soluble cd25 occupancy by il2 in the serum of follicular lymphoma patients

Veeramani, S., Blackwell, S. E., Thiel, W. H., Yang, Z. Z., Ansell, S. M., Giangrande, P. H. & Weiner, G. J., Jan 1 2019, In : Cancer Immunology Research. 7, 9, p. 1511-1522 12 p.

Research output: Contribution to journalArticle

Nucleotide Aptamers
Follicular Lymphoma
Biomarkers
Ligands
Serum
1 Citation (Scopus)

Antibody therapy for non-Hodgkin's lymphoma

Ansell, S. M., Apr 2004, In : Current Opinion in Molecular Therapeutics. 6, 2, p. 175-181 7 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Lymphoma
Monoclonal Antibodies
Antibodies
Combination Drug Therapy
41 Citations (Scopus)

Antilymphoma treatments given subsequent to yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: A review of the literature

Ansell, S. M., Schilder, R. J., Pieslor, P. C., Gordon, L. I., Emmanouilides, C., Vo, K., Czuczman, M. S., Witzig, T. E., Theuer, C. & Molina, A., Dec 2004, In : Clinical Lymphoma. 5, 3, p. 202-204 3 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Therapeutics
Immunoconjugates
B-Cell Lymphoma
ibritumomab tiuxetan
99 Citations (Scopus)

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma

Younes, A., Vose, J. M., Zelenetz, A. D., Smith, M. R., Burris, H. A., Ansell, S. M., Klein, J., Halpern, W., Miceli, R., Kumm, E., Fox, N. L. & Czuczman, M. S., Dec 7 2010, In : British Journal of Cancer. 103, 12, p. 1783-1787 5 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Follicular Lymphoma
TNF-Related Apoptosis-Inducing Ligand Receptors
Staining and Labeling
Disease Progression
36 Citations (Scopus)

A phase 1 study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Dispenzieri, A., Wiseman, G. A., Lacy, M., Litzow, M. R., Anderson, P. M., Gastineau, D. A., Tefferi, A., Inwards, D. J., Micallef, I., Ansell, S. M., Porrata, L., Elliot, M. A., Lust, J. A., Greipp, P. R., Rajkumar, S. V., Fonseca, R., Witzig, T. E., Erlichman, C., Sloan, J. A. & Gertz, M., Jan 2005, In : Leukemia. 19, 1, p. 118-125 8 p.

Research output: Contribution to journalArticle

Melphalan
Multiple Myeloma
Radiopharmaceuticals
Radiation
Bone Marrow

A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma

Dispenzieri, A., D'Souza, A., Gertz, M., Laumann, K., Wiseman, G., Lacy, M., LaPlant, B., Buadi, F., Hayman, S. R., Kumar, S. K., Dingli, D. M., Hogan, W., Ansell, S. M., Gastineau, D. A., Inwards, D. J., Micallef, I., Porrata, L. F., Johnston, P. B., Litzow, M. R. & Witzig, T. E., Oct 1 2017, In : Bone Marrow Transplantation. 52, 10, p. 1372-1377 6 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Multiple Myeloma
Stem Cells
Transplants
Melphalan
5 Citations (Scopus)

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

Rosenthal, A., Dueck, A., Ansell, S. M., Gano, K., Conley, C., Nowakowski, G. S., Camoriano, J. K., Leis, J. F., Mikhael, J. R., Stewart, A. K., Inwards, D., Dingli, D. M., Kumar, S. K., Noel, P., Gertz, M., Porrata, L., Russell, S. J., Colgan, J., Fonseca, R., Habermann, T. M. & 6 others, Kapoor, P., Buadi, F., Leung, N., Tiedemann, R., Witzig, T. E. & Reeder, C., May 1 2017, In : American Journal of Hematology. 92, 5, p. 467-472 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Dexamethasone
Lymphoma
B-Cell Lymphoma

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

Sonbol, M. B., Hilal, T., Dueck, A., Rosenthal, A. C., Conley, C. R., Kosiorek, H. E., Ginos, B. F., Gano, K. M., Nichols, C. S., Leis, J. F., Johnston, P. B., Habermann, T. M., Northfelt, D. W., Bergsagel, P. L., Inwards, D. J., Witzig, T. E., Ansell, S. M. & Reeder, C. B., Jan 11 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cyclophosphamide
Dexamethasone
Safety
Peripheral Nervous System Diseases

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

Larsen, J. T., Hogan, W., Micallef, I., Dispenzieri, A., Gertz, M., Inwards, D. J., Tun, H. W., Roy, V., Geyer, S. M., Allred, J. B., Wu, W., Ansell, S. M., Elliott, M. A., Tefferi, A., Porrata, L. F., Gastineau, D. A., Lacy, M. & Litzow, M. R., Aug 2013, In : Leukemia and Lymphoma. 54, 8, p. 1713-1718 6 p.

Research output: Contribution to journalArticle

Cladribine
Thiotepa
Antilymphocyte Serum
Hematologic Neoplasms
Rabbits
2 Citations (Scopus)

A phase II clinical study of suramin in combination with mitomycin C in patients with non small cell lung cancer

Rapoport, B. L., Falkson, G., Ansell, S. M., Lotz, B. P. & de Wet, M., 1991, In : Lung Cancer. 7, 5, p. 323-328 6 p.

Research output: Contribution to journalArticle

Suramin
Mitomycin
Non-Small Cell Lung Carcinoma
Clinical Studies
Poisons
26 Citations (Scopus)

A phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Dispenzieri, A., Wiseman, G. A., Lacy, M., Hayman, S. R., Kumar, S. K., Buadi, F., Dingli, D. M., Laumann, K. M., Allred, J., Geyer, S. M., Litzow, M. R., Gastineau, D. A., Inwards, D. J., Micallef, I., Ansell, S. M., Porrata, L., Elliott, M. A., Johnston, P. B., Hogan, W. & Gertz, M., Jun 2010, In : American Journal of Hematology. 85, 6, p. 409-413 5 p.

Research output: Contribution to journalArticle

Melphalan
Multiple Myeloma
Radiopharmaceuticals
Hematopoietic Stem Cells
Disease-Free Survival
35 Citations (Scopus)

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): Final results from the T- cell consortium trial

Advani, R. H., Ansell, S. M., Lechowicz, M. J., Beaven, A. W., Loberiza, F., Carson, K. R., Evens, A. M., Foss, F., Horwitz, S., Pro, B., Pinter-Brown, L. C., Smith, S. M., Shustov, A. R., Savage, K. J. & Vose, J. M., Feb 1 2016, In : British Journal of Haematology. 172, 4, p. 535-544 10 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Vincristine
Etoposide
Prednisone
Cyclophosphamide
34 Citations (Scopus)

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

De Vos, S., Forero-Torres, A., Ansell, S. M., Kahl, B., Cheson, B. D., Bartlett, N. L., Furman, R. R., Winter, J. N., Kaplan, H., Timmerman, J., Whiting, N. C., Drachman, J. G. & Advani, R., Jun 12 2014, In : Journal of Hematology and Oncology. 7, 1, 44.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Safety
Chills
Lymphopenia
Conjunctivitis
92 Citations (Scopus)

A phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors

Ansell, S. M., Pitot, H. C., Burch, P. A., Kvols, L. K., Mahoney, M. R. & Rubin, J., Apr 15 2001, In : Cancer. 91, 8, p. 1543-1548 6 p.

Research output: Contribution to journalArticle

Neuroendocrine Tumors
Paclitaxel
Granulocyte Colony-Stimulating Factor
Neutropenia
Islet Cell Adenoma
16 Citations (Scopus)

A phase II trial of a chemotherapy combination in elderly patients with aggressive lymphoma [1]

Ansell, S. M. & Falkson, G., 1993, In : Annals of Oncology. 4, 2, p. 172 1 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Non-Hodgkin's Lymphoma
Remission Induction
Mitoxantrone
Chemotherapy
234 Citations (Scopus)

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Witzig, T. E., Reeder, C. B., Laplant, B. R., Gupta, M., Johnston, P. B., Micallef, I., Porrata, L. F., Ansell, S. M., Colgan, J. P., Jacobsen, E. D., Ghobrial, I. M. & Habermann, T. M., Feb 2011, In : Leukemia. 25, 2, p. 341-347 7 p.

Research output: Contribution to journalArticle

Lymphoma
Non-Hodgkin's Lymphoma
Phosphatidylinositol 3-Kinase
Raptors
Sirolimus
170 Citations (Scopus)

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

Johnston, P. B., Inwards, D. J., Colgan, J. P., Laplant, B. R., Kabat, B. F., Habermann, T. M., Micallef, I., Porrata, L. F., Ansell, S. M., Reeder, C. B., Roy, V. & Witzig, T. E., May 1 2010, In : American Journal of Hematology. 85, 5, p. 320-324 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Everolimus
Phosphatidylinositol 3-Kinase
Raptors
Sirolimus

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

Johnston, P. B., Inwards, D. J., Colgan, J. P., Laplant, B. R., Kabat, B. F., Habermann, T. M., Micallef, I. N., Porrata, L. F., Ansell, S. M., Reeder, C. B., Roy, V. & Witzig, T. E., May 2010, In : American Journal of Hematology. 85, 5, p. 320-324 5 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Everolimus
Phosphatidylinositol 3-Kinase
Raptors
Sirolimus
17 Citations (Scopus)

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma

Witzig, T. E., Wiseman, G. A., Maurer, M. J., Habermann, T. M., Micallef, I., Nowakowski, G. S., Ansell, S. M., Colgan, J. P., Inwards, D. J., Porrata, L. F., Link, B. K., Zent, C. S., Johnston, P. B., Shanafelt, T. D., Allmer, C., Asmann, Y., Gupta, M., Ballas, Z. K., Smith, B. J. & Weiner, G. J., Jul 2013, In : American Journal of Hematology. 88, 7, p. 589-593 5 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Oligodeoxyribonucleotides
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
B-Lymphocytes
31 Citations (Scopus)

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma

Micallef, I., Kahl, B. S., Maurer, M. J., Dogan, A., Ansell, S. M., Colgan, J. P., Geyer, S., Inwards, D. J., White, W. L. & Habermann, T. M., Dec 15 2006, In : Cancer. 107, 12, p. 2826-2832 7 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Vincristine
Prednisone
Doxorubicin
Cyclophosphamide
112 Citations (Scopus)

A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma

Racila, E., Link, B. K., Weng, W. K., Witzig, T. E., Ansell, S. M., Maurer, M. J., Huang, J., Dahle, C., Halwani, A., Levy, R. & Werner, G. J., Oct 15 2008, In : Clinical Cancer Research. 14, 20, p. 6697-6703 7 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Therapeutics
Alleles
Monoclonal Antibodies
Confidence Intervals
38 Citations (Scopus)
Phosphatidylinositol 3-Kinase
Follicular Lymphoma
Cyclin D1
Cell proliferation
Sirolimus
16 Citations (Scopus)

A role for IFN-λ1 in multiple myeloma B cell growth

Novak, A. J., Grote, D. M., Ziesmer, S. C., Rajkumar, S. V., Doyle, S. E. & Ansell, S. M., 2008, In : Leukemia. 22, 12, p. 2240-2246 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Interferons
B-Lymphocytes
Growth
Cytokines
16 Citations (Scopus)

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy

Bachy, E., Maurer, M. J., Habermann, T. M., Gelas-Dore, B., Maucort-Boulch, D., Estell, J. A., Van den Neste, E., Bouabdallah, R., Gyan, E., Feldman, A. L., Bargay, J., Delmer, A., Slager, S. L., da Silva, M. G., Fitoussi, O., Belada, D., Maisonneuve, H., Intragumtornchai, T., Ansell, S. M., Lamy, T. & 5 others, Dartigues, P., Link, B. K., Seymour, J. F., Cerhan, J. R. & Salles, G., Jul 5 2018, In : Blood. 132, 1, p. 49-58 10 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Disease-Free Survival
Bone
Bone Marrow
Chemotherapy
4 Citations (Scopus)
Immunosuppression
Monocytes
Lymphoma
Cytokines
Lymphocytes
18 Citations (Scopus)

AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia

Paulus, A., Chitta, K., Akhtar, S., Personett, D., Miller, K. C., Thompson, K. J., Carr, J., Kumar, S. K., Roy, V., Ansell, S. M., Mikhael, J. R., Dispenzieri, A., Reeder, C. B., Rivera, C. E., Foran, J. M. & Chanan Khan, A. A., Feb 2014, In : British Journal of Haematology. 164, 3, p. 352-365 14 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Multiple Myeloma
Dexamethasone
Plasma Cells
Down-Regulation
121 Citations (Scopus)

Attenuation of CD8+ T-cell function by CD4+CD25 + regulatory T cells in B-cell non-Hodgkin's lymphoma

Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M., Oct 15 2006, In : Cancer Research. 66, 20, p. 10145-10152 8 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Regulatory T-Lymphocytes
Non-Hodgkin's Lymphoma
T-Lymphocytes
Cell Proliferation